239 results on '"Montagner, Alexandra"'
Search Results
2. Dual regulation of TxNIP by ChREBP and FoxO1 in liver
3. Sex differences in metabolic regulation and diabetes susceptibility
4. Hepatic PPARα is critical in the metabolic adaptation to sepsis
5. Estrogen receptor subcellular localization and cardiometabolism
6. Membrane estrogen receptor-α contributes to female protection against high-fat diet-induced metabolic disorders
7. Nuclear and Membrane Actions of Estrogen Receptor Alpha: Contribution to the Regulation of Energy and Glucose Homeostasis
8. The protective role of liver X receptor (LXR) during fumonisin B1-induced hepatotoxicity
9. The interplay between dietary fatty acids and gut microbiota influences host metabolism and hepatic steatosis
10. Author Correction: Dimorphic metabolic and endocrine disorders in mice lacking the constitutive androstane receptor
11. Dimorphic metabolic and endocrine disorders in mice lacking the constitutive androstane receptor
12. Ephrin-B1 regulates the adult diastolic function through a late postnatal maturation of cardiomyocyte surface crests
13. Author response: Ephrin-B1 regulates the adult diastolic function through a late postnatal maturation of cardiomyocyte surface crests
14. The class 3 PI3K coordinates autophagy and mitochondrial lipid catabolism by controlling nuclear receptor PPARα
15. Membrane estrogen receptor-α contributes to female protection against high-fat diet-induced metabolic disorders.
16. ATGL-dependent white adipose tissue lipolysis controls hepatocyte PPARα activity
17. Nuclear and Membrane Actions of Estrogen Receptor Alpha: Contribution to the Regulation of Energy and Glucose Homeostasis
18. The hepatocyte insulin receptor is required to program the liver clock and rhythmic gene expression
19. Nuclear HMGB1 protects from nonalcoholic fatty liver disease through negative regulation of liver X receptor
20. Crest maturation at the cardiomyocyte surface contributes to a new late postnatal development stage that controls the diastolic function of the adult heart
21. Contributions of peroxisome proliferator-activated receptor β/δ to skin health and disease
22. Nuclear receptor peroxisome proliferator activated receptor (PPAR) β/δ in skin wound healing and cancer
23. Noonan syndrome-causing SHP2 mutants inhibit insulin-like growth factor 1 release via growth hormone-induced ERK hyperactivation, which contributes to short stature
24. Activation of the Constitutive Androstane Receptor induces hepatic lipogenesis and regulates Pnpla3 gene expression in a LXR-independent way
25. Liver PPARα is crucial for whole-body fatty acid homeostasis and is protective against NAFLD
26. Endoplasmic reticulum stress controls iron metabolism through TMPRSS6 repression and hepcidin mRNA stabilization by RNA-binding protein HuR
27. Roles of Estrogens in the Healthy and Diseased Oviparous Vertebrate Liver
28. Integrative study of diet-induced mouse models of NAFLD identifies PPARα as a sexually dimorphic drug target
29. Nuclear HMGB1 protects from non-alcoholic fatty liver diseases through negative regulation of liver X receptor
30. The hepatocyte insulin receptor is required to program rhythmic gene expression and the liver clock
31. Src is activated by the nuclear receptor peroxisome proliferator-activated receptor β/δ in ultraviolet radiation-induced skin cancer
32. ATGL-dependent white adipose tissue lipolysis controls hepatocyte PPARα activity
33. The liver X receptor: A master regulator of the gut–liver axis and a target for non alcoholic fatty liver disease
34. Beneficial effects of combinatorial micronutrition on body fat and atherosclerosis in mice
35. Peroxisome Proliferator-Activated Receptors and Their Novel Ligands as Candidates for the Treatment of Non-Alcoholic Fatty Liver Disease
36. Hepatocyte-specific deletion of Pparα promotes NAFLD in the context of obesity
37. Proton NMR Enables the Absolute Quantification of Aqueous Metabolites and Lipid Classes in Unique Mouse Liver Samples
38. Sex differences in metabolic regulation and diabetes susceptibility
39. Sex dimorphic role of estrogen receptor a in physiological regulation of hepatic metabolism
40. Selective Liver Estrogen Receptor Modulation Prevents Steatosis, Diabetes, and Obesity Through the Anorectic Growth Differentiation Factor 15 Hepatokine in Mice
41. Constitutive Androstane Receptor deficiency leads to sexually dimorphic metabolic disorders in aging
42. Influence of gender on progression of liver metabolic diseases in response to different nutritional challenges
43. Integrative study of diet-induced mouse models of NAFLD identifies PPARα as a sexually dimorphic drug target
44. GW501516-activated PPARβ/δ promotes liver fibrosis via p38-JNK MAPK-induced hepatic stellate cell proliferation
45. Hepatokines in metabolic disease: novel insights into FGF21 regulation by glucose
46. Selective Liver Estrogen Receptor α Modulation Prevents Steatosis, Diabetes, and Obesity Through the Anorectic Growth Differentiation Factor 15 Hepatokine in Mice
47. Hepatocyte-specific deletion of Pparα promotes NASH in the context of obesity
48. The protective role of liver X receptor (LXR) during fumonisin B1-induced hepatotoxicity
49. β-catenin oncogenic activation rewires fatty acid catabolism to fuel hepatocellular carcinoma
50. Insights into the role of hepatocyte PPARα activity in response to fasting
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.